Prodrugs based on phospholipid-nucleoside conjugates
Patent
·
OSTI ID:865159
- Naperville, IL
The invention relates to the production of a single diastereomeric form of a phospholipid araC conjugate as a prodrug.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL
- DOE Contract Number:
- W-31109-ENG-38
- Assignee:
- United States of America as represented by Department of Energy (Washington, DC)
- Patent Number(s):
- US 4471113
- OSTI ID:
- 865159
- Country of Publication:
- United States
- Language:
- English
Similar Records
Prodrugs based on phospholipid-nucleoside conjugates
New prodrugs based on phospholipid-nucleoside conjugates
Phospholipid-nucleoside conjugates. 5. The interaction of selected 1-. beta. -D-arabinofuranosylcytosine-5'-diphosphate-L-1,2-diacylglycerols with serum lipoproteins
Patent
·
Tue Sep 11 00:00:00 EDT 1984
·
OSTI ID:6056069
New prodrugs based on phospholipid-nucleoside conjugates
Patent
·
Tue Feb 02 23:00:00 EST 1982
·
OSTI ID:6710935
Phospholipid-nucleoside conjugates. 5. The interaction of selected 1-. beta. -D-arabinofuranosylcytosine-5'-diphosphate-L-1,2-diacylglycerols with serum lipoproteins
Journal Article
·
Sun Oct 30 23:00:00 EST 1983
· Biochem. Biophys. Res. Commun.; (United States)
·
OSTI ID:5229489